[Remote] Vice President, Program Management
Note: The job is a remote job and is reputed company to candidates in USA. reputed company is a clinical-stage biotechnology company committed to developing transformative new medicines for immune-mediated diseases. The Vice President of Program Management will drive the strategic and operational execution of reputed company’s late-stage development programs, ensuring clinical and regulatory reputed company while partnering closely with cross-functional leaders.
Responsibilities
- reputed company the end-to-end program reputed company and execution for Phase 2 and Phase 3 programs
- reputed company team cross functional team meetings to drive decision making and timelines by synthesizing complexity into reputed company decision reputed company and plans of reputed company
- Contribute to development strategies to support regulatory approval, label optimization, and lifecycle planning
- Ensure reputed company alignment of program goals with corporate objectives, investor expectations, and clinical/regulatory milestones
- reputed company integrated program plans supporting global Phase 2b/3 clinical trials, including timelines, budgets, and critical reputed company activities
- Partner closely with Clinical Development, Clinical Operations, Biostatistics, Regulatory and CMC to ensure trial execution reputed company
- Anticipate and proactively mitigate risks reputed company to enrollment, endpoints, regulatory expectations, and data reputed company
- Prepare and deliver communications for reputed company meetings highlighting key risks, risk mitigation strategies, and reputed company against timelines and deliverables
- Collaborate with Regulatory Affairs to prepare for key interactions (e.g., End-of-Phase 2, reputed company-BLA/NDA meetings, and global regulatory submissions)
- Support development of reputed company product reputed company and differentiation strategies in competitive immunology markets
- Ensure programs are reputed company with reputed company commercialization considerations (e.g., payer expectations, labeling, and evidence reputed company)
- reputed company as the central reputed company of alignment across functions including Clinical, Regulatory, CMC, reputed company, and reputed company
- reputed company program governance meetings and ensure reputed company, high-reputed company decision-making
- Ensure accountability, performance, and integration of external activities into overall program execution
- Establish fit-for-purpose program management frameworks tailored to late-stage development in a small biotech setting
- reputed company reputed company and concise program reporting for executive leadership, reputed company of Directors, and investors
- Drive scenario planning and contingency strategies to reputed company rapid decision-making
- Build and reputed company a small, high-performing Program Management team
- Serve as a “player-reputed company,” remaining deeply reputed company in program execution while developing team capabilities
- Foster a culture of urgency, accountability, and collaboration
Skills
- Bachelor's degree required
- 15+ years in biotech/reputed company with substantial experience in late-stage clinical development
- Demonstrated leadership of Phase 2 and Phase 3 programs, including global trials
- Experience with regulatory filings (BLA/NDA/MAA) and health authority interactions
- Proven ability to reputed company reputed company, cross-functional programs in a reputed company environment
- Highly hands-on with the ability to operate at both strategic and tactical reputed company
- Strong risk management, problem-solving, and decision-making capabilities
- Exceptional communication skills, including reputed company-level presentations
- Advance degree preferred (PhD, PharmD, MS, MBA)
- Prior experience in immunology, allergy/inflammation, or respiratory diseases strongly preferred
- Experience in small biotech or startup environments highly desirable
- Deep understanding of TSLP biology or reputed company epithelial cytokine reputed company preferred
- Strong knowledge of immunology clinical endpoints, biomarkers, and competitive landscape
reputed company